Ma­jor drug price re­forms head for Biden's sig­na­ture as PhRMA weighs le­gal op­tions

3 years ago
Pharma
Law

Catal­ent ac­quires North Car­oli­na CD­MO for $475M, boost­ing oral solids work

3 years ago
Deals
Manufacturing

Phar­mas spend mil­lions on di­a­betes ad­ver­tis­ing, but few pa­tients can re­call brand names — sur­vey

3 years ago
Pharma
Marketing

Faced with thou­sands of opi­oid law­suits, En­do says it will like­ly file for bank­rupt­cy 'im­mi­nent­ly'

3 years ago
Pharma
Law

Bris­tol My­ers flash­es a thumbs-up on piv­otal push to ex­pand Abec­ma's BC­MA CAR-T mar­ket

3 years ago
Pharma
Cell/Gene Tx

Pen­ny stock biotech miss­es on its sole clin­i­cal tri­al; Cal­adrius teams up with Roche for pan­cre­at­ic can­cer ...

3 years ago
News Briefing

Af­ter FDA re­vokes EUA for GSK-part­nered mAb, Vir changes its plans on Covid-19 treat­ments

3 years ago
R&D
Coronavirus

In bid for new T cell ther­a­pies, Bris­tol My­ers inks deal with Treg play­er Gen­tiBio

3 years ago
Deals

Up­dat­ed: 'Close to the mid­dle': Ver­sant launch­es Vec­tor with 'gut­less ade­n­ovirus' de­liv­ery method

3 years ago
Financing
Startups

On heels of pos­i­tive COPD read­out, Verona to pro­vide new pub­lic of­fer­ing

3 years ago
Financing

Ab­sci lays off staff as it looks to re­or­ga­nize amid stock falloff, bear mar­ket

3 years ago
People
Manufacturing

Feud be­tween two biotechs left near­ly 12M dos­es of mon­key­pox an­tivi­ral on the ta­ble

3 years ago
Pharma

One of 2021's star biotech play­ers flags an­oth­er big set­back for the pipeline

3 years ago
R&D

Who are the women blaz­ing trails in bio­phar­ma R&D? Nom­i­nate them for End­points' 2022 spe­cial re­port

3 years ago
Editor's note

Disc Med­i­cine goes pub­lic in re­verse merg­er with strug­gling Gem­i­ni Ther­a­peu­tics

3 years ago
Deals

Up­dat­ed: Amid mas­sive re­struc­tur­ing, Bio­gen looks to re­duce phys­i­cal pres­ence in Boston

3 years ago
Pharma

Hop­ing to ex­pand mon­key­pox vac­cine sup­ply, US paves the way for new route of ad­min­is­tra­tion

3 years ago
FDA+

Up­dat­ed: Any­one still look­ing for a CD47? Zai Lab shelves PhI pro­gram af­ter re­view­ing 'com­pet­i­tive land­scape'

3 years ago
R&D

Civi­ca, Mayo Clin­ic and oth­ers sound off on FDA draft guid­ance to mit­i­gate drug short­ages

3 years ago
Pharma
FDA+

US weighs new route of ad­min­is­tra­tion for mon­key­pox vac­cine as cas­es climb — re­port

3 years ago
Pharma

To avoid short­age of Mer­ck­'s di­a­betes drug, FDA al­lows high­er im­pu­ri­ty lev­els tem­porar­i­ly

3 years ago
FDA+
Manufacturing

Work­ers at Pfiz­er Aus­tralian man­u­fac­tur­ing site the lat­est to walk out in la­bor dis­pute protests

3 years ago
People
Pharma

'Messy at best': Is the US re­peat­ing the same Covid mis­steps with mon­key­pox mes­sag­ing?

3 years ago
Pharma
Marketing

Mar­ket­ingRx roundup: Ab­b­Vie re­fresh­es Skyrizi and Rin­voq cam­paigns; Ab­bott inks Weight­Watch­ers deal

3 years ago
Pharma
Marketing
First page Previous page 481482483484485486487 Next page Last page
A service from the Financial Times